MBOAT7 and Hyperinsulinemia: Another key question that has come from mouse studies is how to reconcile the fact that either ASO- or MPO-mediated silencing of Mboat7 (which can target multiple cell types) promotes profound hyperinsulinemia and systemic insulin resistance (37, 38).